Golden
Bioeconomy Capital

Bioeconomy Capital

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

Completion of Bioeconomy Fund 1

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

Investments



Timeline

January 1, 2017

Completion of Bioeconomy Fund 1

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

Funded Companies

2 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Synthace is a software company based out of London, UK building automation software that gives biologists the ability to control and analyze the performance of lab hardware.

Arzeda is a biotechnology and software company designing custom microorganisms for industrial applications through computational enzyme design, protein optimization, and metabolic engineering.

People

Name
Role
LinkedIn

Rik Wehbring

Founder & managing director (San Francisco)



Rob Carlson

Founder & managing director (Seattle)



Tim Fell

Employee



Tim Gardner

Employee



Further reading

Title
Author
Link
Type
Date

GBS 2018: Bioeconomy leaders foster shift to sustainable industry production

BIOCOM AG

News article



Xconomy: Seattle Area Had a Middling 2017 for Venture Investment, Fundraising

Benjamin Romano

News article



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References